Status:
COMPLETED
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Acute Graft-versus-Host Disease
Allogeneic Stem Cell Transplant
Eligibility:
All Genders
18+ years
Brief Summary
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease (GVHD).
Detailed Description
The purpose of this study is to examine whether the expression levels of a novel class of molecules, called microRNAs, are associated with acute graft-versus-host disease frequency and severity. Acute...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who are receiving allogeneic stem cell transplantation at the Ohio State University Blood and Marrow Transplantation program are eligible and will be consented for the study.
Exclusion
Key Trial Info
Start Date :
February 20 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
259 Patients enrolled
Trial Details
Trial ID
NCT01521039
Start Date
February 20 2012
End Date
December 30 2024
Last Update
January 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Medical Center
Columbus, Ohio, United States, 43210